Biomason Funding, Investors & Competitors

Biomason has raised $127M across 5 funding rounds, most recently a $37M undisclosed-stage round in January 2025.

Last Biomason funding round

$37M

Undisclosed stage · Jan 2025

Cumulative funding Biomason raised

$127M

across 5 funding rounds

Key investors in Biomason

Biomason Overview

About Biomason

Biomason is a Durham-headquartered biotechnology company manufacturing biocement using microbial-induced mineralization at ambient temperatures. Since 2012, its processes produce carbon-negative bricks and pavers from aggregate and bacteria, deployed in commercial projects across the United States and Europe including precast bioLITH tiles.


Founded

2012

HQ

United StatesDurham, NC

Status

Privately held

Customer focus

B2B

Revenue model

Product sales

Biomason Funding History

Biomason has raised a total of $127M across 5 funding rounds.

Biomason's first fundraising round was a $500K seed round in September 2013. The most recent completed round was a $37M undisclosed-stage round in January 2025.

Biomason funding rounds

Biomason funding rounds
DateStageInvestorsRaisedDeal Summary
Jan 2025Undisclosed stage-$37MBiomason is a Research Triangle Park-based company founded in 2012 that develops biocement, a sustainable construction material grown from microorganisms to replace traditional cement and reduce the concrete industry's carbon emissions, targeting elimination of 25% of emissions by 2030. The company produces biocement used across the US and Europe, bio-based tiles under the Biolith brand, and has demonstrated applications with DARPA and partnerships like H&M Group and IBF. It operates a factory in Denmark and aims to decarbonize concrete, the second most consumed substance responsible for 8% of global emissions via cement. Biomason raised a $65 million Series C round in February 2022, led by 2150 with participation from Celesta Capital, Hartree Partners, Novo Holdings, and Martin Marietta Materials, to accelerate technology development, hiring, commercialization, and broader applications like ready-mix technology. Prior funding included $5 million out of $18 million targeted in 2019, $1.5 million in 2015, and $500,000 earlier, plus loans from the North Carolina Biotechnology Center totaling $800,000. In early 2025, under new CEO Camilo Restrepo, Biomason disclosed raising over $36 million from six investors via a securities filing, part of a planned $50.8 million raise capped amount, with $20.8 million from convertible note conversions and $14.2 million remaining. Investors were not specified but likely include prior backers like 2150, Celesta, Hartree, Martin Marietta, Novo, and Acorn Innovestments. The company has grown to over 100 employees across 55 disciplines, with products installed in North America and Europe, focusing on scaling biocement for global impact in the built environment.
Feb 2022Series C2150 (lead); Novo Holdings; Martin Marietta Materials; Hartree Partners; Celesta Capital$65MBiomason, based in Research Triangle Park, North Carolina, develops biocement technology that uses microorganisms to produce cement without high-heat kilns or CO2 emissions from calcination, aiming to eliminate 25% of global concrete industry carbon emissions by 2030. The company produces products like bioLITH precast tiles, which are commercially available, and has installed biocement-powered products across North America and Europe. It has over 100 employees across 55 disciplines and collaborations with DARPA, H&M Group, and IBF for scaling applications. On February 28, 2022, Biomason announced a $65 million Series C funding round led by 2150, with participation from Celesta Capital, Hartree Partners, Novo Holdings, and Martin Marietta Materials. The funds are intended to accelerate development of its proprietary biocement platform for broader applications in the concrete value chain and support commercialization efforts. Biomason had previously raised funds in earlier rounds, including a Series B in 2019, and continued with a grant in November 2022 and a Series D in January 2025 for $36.67M from similar investors including 2150, Celesta Capital, Hartree Partners, Martin Marietta, and Novo Holdings.
Dec 2019Undisclosed stage-$23MBiomason is a Research Triangle Park-based biotech company developing biocement technology that uses microorganisms to grow sustainable construction materials, aiming to reduce carbon emissions from the cement industry. The company publicly launched in 2019 and had raised prior funding including $1.5M in 2015 and $500,000 in 2013 from unnamed investors, plus debt. This brought total capital raised to about $2M equity and $3.4M debt historically. Early support came from North Carolina Biotechnology Center loans totaling $800k. Biomason's technology enables proprietary manufacturing processes for biocement-based products, licensed for incorporation into existing facilities or on-site production. The 2019 round supported early commercialization efforts as the company looked toward 2020 expansion, including contributions from the founder's savings. By later stages, Biomason grew to over 100 employees across 55 disciplines, installing products in North America and Europe, partnering with DARPA, H&M Group, and IBF.
Dec 2015SeedAcorn Innovestments$2M-
Sep 2013Seed-$500K-

Who has invested in Biomason?

6 investors have backed Biomason across its funding rounds, including Novo Holdings, Celesta Capital, 2150, Hartree Partners, Martin Marietta Materials and Acorn Innovestments.

Lead investors include 2150.


Biomason Investors

Investors in Biomason by funding rounds participated
InvestorHQRoundsRoleFirst check
Novo HoldingsDenmarkCopenhagen1ParticipantFeb 2022
2150DenmarkLondon1LeadFeb 2022
Martin Marietta MaterialsUnited StatesRaleigh, NC1ParticipantFeb 2022
Acorn InnovestmentsUnited StatesDurham, NC1ParticipantDec 2015

This data is available for Pro users. Sign up to see all 6 Biomason investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Biomason Competitors

Biomason competitors include listed companies like CRH, Holcim, Martin Marietta Materials and UltraTech Cement, and private ones like Lafarge India and Tigre.

Public and private companies comparable to Biomason
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
CRHUnited StatesUnited StatesPublicly listed$37B$7.6B$58B1.9x
HolcimSwitzerlandSwitzerlandPublicly listed$19B$2.8B$46B2.7x
Martin Marietta MaterialsUnited StatesUnited StatesPublicly listed$6.2B$2.1B$35B5.8x
UltraTech CementIndiaIndiaPublicly listed$9.1B$1.8B$33B3.6x
Lafarge IndiaSwitzerlandZurichPrivate--$1.2B-
TigreBrazilJoinvillePrivate-$145M$918M-

Biomason Public Comps

Biomason is still privately-owned, but its public comps include CRH, Holcim, Martin Marietta Materials, UltraTech Cement, Vulcan Materials, Heidelberg Materials, Grasim Industries, Amrize, James Hardie Industries and CEMEX.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
CRH$37B$7.6B2.0x1.9x10.0x9.4x
Holcim$19B$2.8B2.9x2.7x19.9x11.0x
Martin Marietta Materials$6.2B$2.1B6.7x5.8x19.8x17.1x
UltraTech Cement$9.1B$1.8B3.9x3.6x19.9x18.6x
Vulcan Materials$7.9B$2.3B4.6x4.5x15.5x15.1x
Heidelberg Materials$25B$5.1B1.6x1.5x7.5x7.0x
Grasim Industries$18B$2.6B2.7x10.7x18.9x196.9x
Amrize$12B$2.8B2.3x2.2x9.8x8.9x

This data is available for Pro users. Sign up to see all Biomason competitors and their valuation data.

Start Free Trial

Common questions about Biomason

When was Biomason founded?Biomason was founded in 2012.
Where is Biomason headquartered?Biomason is headquartered in Durham, NC, United States.
Is Biomason publicly listed?No, Biomason is a private, VC-backed company.
How much funding has Biomason raised?Biomason has raised $127M across 5 funding rounds.
What was Biomason's last funding round?Biomason's last funding round was a $37M undisclosed-stage round in January 2025.
Who are Biomason's investors?Biomason's investors include Novo Holdings, 2150, Martin Marietta Materials, Acorn Innovestments, Hartree Partners and Celesta Capital.
Which companies are comparable to Biomason?Companies comparable to Biomason include CRH, Holcim, Martin Marietta Materials, UltraTech Cement, Lafarge India and Tigre.

See companies similar to Biomason

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial